MICHELLE GALLIGAN: Open Payments
NPI 1215789805 · BANNOCKBURN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $117 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Abbott Laboratories | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Medtronic, Inc. | 1 | $15 |
Products named: LEQVIO, WAINUA, Ozempic, CARDIOMEMS, VERQUVO, Wegovy, COREVALVE EVOLUT R, FARXIGA.
Industry payments across IL — which companies pay providers there.
